Article
- The EMBO Journal (1999) 18, 2106 - 2118
- doi:10.1093/emboj/18.8.2106
The p16INK4a tumour suppressor protein inhibits
v
3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of
v
3 to focal contacts
Robin Fåhraeus1 and David P. Lane1
- CRC Laboratories, Department of Biochemistry, University of Dundee, Dundee DD1 4HN, UK
Correspondence to:
Robin Fåhraeus, E-mail: rfahraeus@bad.dundee.ac.uk
Received 2 November 1998; Accepted 23 February 1999; Revised 8 February 1999
Abstract
Expression of full-length p16INK4a blocks
v
3 integrin-dependent cell spreading on vitronectin but not collagen IV. Similarly, G1-associated cell cycle kinases (CDK) inhibitory (CKI) synthetic peptides derived from p16INK4a, p18INK4c and p21Cip1/Waf1, which can be delivered directly into cells from the tissue culture medium, do not affect non-
v
3-dependent spreading on collagen IV, laminin and fibronectin at concentrations that inhibit cell cycle progression in late G1. The
v
3 heterodimer remains intact after CKI peptide treatment but is immediately dissociated from the focal adhesion contacts. Treatment with phorbol 12-myristate 13-acetate (PMA) allows
v
3 to locate to the focal adhesion contacts and the cells to spread on vitronectin in the presence of CKI peptides. The cdk6 protein is found to suppress p16INK4a-mediated inhibition of spreading and is also shown to localize to the ruffling edge of spreading cells, indicating a function for cdk6 in controlling matrix-dependent cell spreading. These results demonstrate a novel G1 CDK-associated integrin regulatory pathway that acts upstream of
v
3-dependent activation of PKC as well as a novel function for the p16INK4a tumour suppressor protein in regulating matrix-dependent cell migration.
Keywords:
v
3 integrin, - cancer,
- integrin regulatory pathway,
- p16INK4a tumour suppressor protein



